CONTACT US
OUR ADDRESS

Crohn’s Disease

TREATMENT

Crohn’s disease is a condition that causes chronic inflammation or ulcers in the mucous lining of the small and large intestines, particularly affecting young people. It is a type of inflammatory bowel disease (IBD) characterized by inflammation that can occur anywhere from the mouth to the anus. As such, Crohn’s disease is recognized as a designated intractable disease and often severely impacts the quality of life of patients.
In recent years, stem cell therapy has attracted attention as a promising treatment for Crohn’s disease. Especially mesenchymal stem cells (MSCs), due to their immune regulatory abilities and tissue repair and regeneration capabilities, are considered effective in reducing inflammation and promoting tissue regeneration.

The anticipated outcomes of stem cell therapy are as follows

The currently common treatments for Crohn’s disease include immunosuppressants and biologics; however, their effectiveness is often limited, creating an urgent need for new treatment methods.

Stem cell therapy, as an emerging treatment, is gaining widespread attention. Clinical trials conducted worldwide have begun using amniotic mesenchymal stem cells (amniotic MSC) to treat Crohn’s disease, and their efficacy and safety have been confirmed.
Stem cell therapy is expected to promote the repair of inflammation caused by Crohn’s disease and effectively suppress symptom exacerbation during acute flare-ups.

Conditions Treated